Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (201-210 of 560) with videos related to

Pageof 56
Sort By:
Oncogene|May 23, 2006
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapyX-F Wen, G Yang, W Mao, et al.
Journal of the National Cancer Institute|November 1, 1974
Intracolonic injection of BCG in the rhesus monkeyR C Bast, W G Doos, B Zbar, et al.
Cancer|July 1, 1994
Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascitesJ Hurteau, G C Rodriguez, R S Whitaker, et al.
American Journal of Clinical Pathology|February 1, 1994
Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysisB J Kerns, P A Jordan, L L Faerman, et al.
American Journal of Obstetrics and Gynecology|April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixJ M Niloff, T L Klug, E Schaetzl, et al.
Obstetrics and Gynecology|February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapyP T Lavin, R C Knapp, G Malkasian, et al.
In Vivo (Athens, Greece)|July 1, 1995
Toward salivary-urinary chronosensitivity testing: chronomes of OVX1, M-CSF and CA130F Xu, Y Yu, R C Bast, et al.
Cancers|May 5, 2019
Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional RepressionMargie N Sutton, Gilbert Y Huang, Jinhua Zhou, et al.
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancerG Olt, J Soper, S Ramakrishnan, et al.
Pageof 56

Showing results (201-210 of 560) with videos related to

Sort By:
Pageof 56
Oncogene|May 23, 2006
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapyX-F Wen, G Yang, W Mao, et al.
Journal of the National Cancer Institute|November 1, 1974
Intracolonic injection of BCG in the rhesus monkeyR C Bast, W G Doos, B Zbar, et al.
Cancer|July 1, 1994
Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascitesJ Hurteau, G C Rodriguez, R S Whitaker, et al.
American Journal of Clinical Pathology|February 1, 1994
Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysisB J Kerns, P A Jordan, L L Faerman, et al.
American Journal of Obstetrics and Gynecology|April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixJ M Niloff, T L Klug, E Schaetzl, et al.
Obstetrics and Gynecology|February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapyP T Lavin, R C Knapp, G Malkasian, et al.
In Vivo (Athens, Greece)|July 1, 1995
Toward salivary-urinary chronosensitivity testing: chronomes of OVX1, M-CSF and CA130F Xu, Y Yu, R C Bast, et al.
Cancers|May 5, 2019
Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional RepressionMargie N Sutton, Gilbert Y Huang, Jinhua Zhou, et al.
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancerG Olt, J Soper, S Ramakrishnan, et al.
Pageof 56